CFC inhalers to be phased out by 2003

The European Commission has adopted a strategy, as required under the Montreal Protocol, for phasing out the use of CFCs in metered dose inhalers (MDIs). CFCs are still available for use in MDIs under the Protocol's "essential uses" exemption. Worldwide, 500 million MDIs are used each year, of which 200 million are made in Europe, using 6,635 tonnes of CFCs.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Take a 30-day trial

  • Join ENDS Report now and pay nothing for your first 30-days.



Prices on request

  • Full access to for 12 months
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access